Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

January 17, 2021

Counseling, Targeted Interventions Needed to Improve Health-Related Quality of Life in Young Colon Cancer Survivors

Author(s):

Conor Killmurray
Conference|ASCO Gastrointestinal Cancers Symposium

The researchers concluded that the overall low health-related quality of life scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, which could include counseling and quality of life interventions.

Data presented at the 2021 American Society of Clinical Oncology Gastrointestinal Cancers Symposium demonstrated that as the incidence of colorectal cancer in patients under 50-years-old increases, overall health-related quality of life among younger survivors is poorer, with their social and functional well-being suffering more as treatment duration grows longer.

Using the Functional Assessment of Cancer Therapy (FACT-C) survey, which assesses health-related quality of life (HRQoL) globally, along with a cross-sectional online survey for a CRC-specific scale that looked at emotional, physical, social, and functional well-being domains, researchers evaluated the responses of 235 patients with colorectal cancer (CRC) and found an overall low score of HRQoL of 67.3 out of a possible 136 in this patient population.

The mean age of the sample was 33.76 years old and the location of the patients’ tumors were either in the colon (41.7%) or rectum (58.3%). The majority of patients (33.23%) were diagnosed with stage 2 cancer and 98% were non-metastatic, while 42% experienced relapse of their disease. One hundred and eighty-nine patients (61.4%) were six to 18 months from their diagnosis or relapse, but important demographic figures like age and ethnicity did not have a significant statistical difference between the two groups.

Patients were split into two categories of six to 18 months from their initial diagnosis or relapse, and 19 to 36 months from diagnosis or relapse. While researchers did not find a significant difference between the two groups in terms of emotional and physical well-being, scores were low across all domains, with social well-being the highest (15.15/28) and emotional well-being the lowest (11.44/24). Moreover, functional well-being rated close to the bottom (11.84/28), with physical well-being the second highest (15.15/28).

Higher scores for physical and emotional well-being were observed in patients who had a longer time between diagnosis compared to short-term, whereas significantly lower scores were observed in social well-being for patients who had a shorter time between their diagnosis and the survey, at 15.24/28 versus 14/28 respectively. This was also observed in functional well-being, which scored at 13.2 for the six to 18-month group versus 11.12 for the 19 to 36-month group.

The researchers concluded that with the overall low HRQoL scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, as they were the lowest. These methods would include counseling and quality of life interventions, but further study into which of these methods would be best is needed.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Eng.
Image of man with black hair.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Related Content
Advertisement
Picture of FDA offices
August 23rd 2025

FDA Approves Dako Omnis Test to Guide Colorectal Cancer Treatment

Spencer Feldman
Teri Greige with medals
August 23rd 2025

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
The FDA approved an IND application for ABT-301 in metastatic colorectal cancer: © stock.adobe.com.
August 23rd 2025

FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer

Alex Biese
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
August 23rd 2025

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
Some patients with advanced colorectal cancer responded to leronlimab: © stock.adobe.com.
August 23rd 2025

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

Spencer Feldman
Photo of a person with an illustrated gastrointestinal tract in front of them
August 23rd 2025

Zanzalintinib Combo Improves Survival in Metastatic Colorectal Cancer

Spencer Feldman
Related Content
Advertisement
Picture of FDA offices
August 23rd 2025

FDA Approves Dako Omnis Test to Guide Colorectal Cancer Treatment

Spencer Feldman
Teri Greige with medals
August 23rd 2025

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
The FDA approved an IND application for ABT-301 in metastatic colorectal cancer: © stock.adobe.com.
August 23rd 2025

FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer

Alex Biese
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
August 23rd 2025

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
Some patients with advanced colorectal cancer responded to leronlimab: © stock.adobe.com.
August 23rd 2025

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

Spencer Feldman
Photo of a person with an illustrated gastrointestinal tract in front of them
August 23rd 2025

Zanzalintinib Combo Improves Survival in Metastatic Colorectal Cancer

Spencer Feldman
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.